APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...

Supply chain optimization software maker Manhattan Associates (NASDAQ:MANH) reported Q4 CY2024 results , with sales up 7.4% ...

U.S. crude inventories climbed by 3.463 million barrels during the recent week, compared to market estimates of a 3.2 million-barrel gain, according to the Energy Information Administration. In ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

US-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the investigational review board (IRB) ...

Zacks Small Cap Research was hard at work in 2024 initiating ... December 10, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) will host its Investor and Analyst Day in Boston today.

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.